Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences
The United States has experienced substantial increases in opioid use for more than two decades. The impacts of this growth have impacted rural areas where overdoses have risen drastically during this time period and more often involve prescription opioids than in urban areas. Medications for opioid use disorders (MOUDs) are highly underutilized in rural settings due to lack of access, inadequate prescribing, and stigma. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - September 4, 2023 Category: Addiction Authors: Aaron R. Brown, Jayme Walters, Beth Harmer, Lara Cates, Aubrey E. Jones Source Type: research

Choice of high-deductible health plans among enrollees with a substance use disorder
In this study, we examine the factors associated with an individual with an SUD's decision to enroll in an HDHP. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 30, 2023 Category: Addiction Authors: Mark K. Meiselbach, Haiden A. Huskamp, Julia C.P. Eddelbuettel, Alene Kennedy-Hendricks, Mara A.G. Hollander, Cameron Schilling, Alisa B. Busch, Elizabeth A. Stuart, Colleen L. Barry, Matthew D. Eisenberg Source Type: research

18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies
Few studies investigate the natural history of patients on long-term treatment for opioid use disorder (OUD). We evaluated the long-term efficacy, safety, and tolerability experience of monthly extended-release buprenorphine (BUP-XR) in participants seeking treatment for OUD, via integrated analysis of phase 3 studies. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Daniel Rutrick, Susan M. Learned, Brent Boyett, David Hassman, Sunita Shinde, Yue Zhao Source Type: research

What can we learn from COVID-19 to improve opioid treatment? Expert providers respond
The COVID-19 pandemic has had devasting effects on drug abuse treatment systems already stressed by the opioid crisis. Providers within opioid use disorder (OUD) outpatient treatment programs have had to adjust to rapid change and respond to new service delivery provisions such as telehealth and take-home medication. Using the COVID-19 pandemic and subsequent organizational challenges as a backdrop, this study explores providers' perspectives about strategies and policies that, if made permanent, can potentially improve access to and quality of OUD treatment. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Lesley M. Harris, Jeanne C. Marsh, Tenie Khachikian, Veronica Serrett, Yinfei Kong, Erick G. Guerrero Source Type: research

Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care
The objective of this study is to determine the rate of falsification of UDS testing among patients with OUD in active treatment with buprenorphine via a telehealth provider. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Rebekah Rollston, Barbara Burke, Scott G. Weiner, Winifred Gallogly, Apryl D. Brandon, Robyn Carter, Brian Clear Source Type: research

The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and action
Injectable opioid agonist treatment (iOAT) is an evidence-based treatment that serves an important minority of people with opioid use disorder who require specialized care. Unique to iOAT care is the consistency with which clients access treatment (up to three times daily), a condition that creates repeated opportunities for health care engagement. To date, no study has examined therapeutic relationships in this life saving, nurse-led treatment that can have lasting implications in the equitable delivery of other forms of addictions care. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Sarin Blawatt, Scott Harrison, David Byres, Julie Foreman, Sherif Amara, Wistaria Burdge, Scott MacDonald, Martin Schechter, Eugenia Oviedo-Joekes Source Type: research

Pilot randomized controlled trial of a brief strategy to prevent suicide after discharge from residential addiction treatment
Veterans are at greater risk for suicide and veterans with substance use disorder (SUD) have an even greater risk. Little research has looked into brief interventions to prevent suicide in this population in residential substance use treatment programs. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 29, 2023 Category: Addiction Authors: Lauren Kenneally, Susan Stevens, Sarah Cornelius, Brian Shiner, Korie Rice, Jenna Park, Bradley Watts, Nikhil Teja, Natalie Riblet Source Type: research

Relationship between medication adherence for opioid use disorder and health care costs and health care events in a claims dataset
Medication for opioid use disorder (MOUD) has well-documented benefits for treating OUD, though its efficacy depends on patient adherence. We know little about outcomes of MOUD nonadherence compared to treatment regimens without MOUD, and this article aims to address the gap. This analysis focused on office-based MOUD treatment (buprenorphine and naltrexone) to evaluate the long-term impact of adherence on subsequent health care costs and health care events. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 11, 2023 Category: Addiction Authors: Shirley Liao, Steve Jang, Jordan A. Tharp, Natalie A. Lester Source Type: research

“I thought it was for guys that did needles”: Medication perceptions and lay expertise among medical research participants
Although randomized controlled trials (RCTs) examine “objective” indicators of safety and efficacy of investigational drugs, participants may not perceive study medications as neutral entities. Some medications are imbued with social and cultural meaning, such as stigmatized medications for opioid use disorders. Such perceptions surrounding substa nce use treatments can extend to the research context and shape RCT participants' experiences with and adherence to study medications. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 10, 2023 Category: Addiction Authors: Kaitlyn Jaffe, Lindsey Richardson Source Type: research

Editorial: Special issue on racism, racial identity, and substance use
Despite recent improvements in substance use disorder (SUD) treatment, such as increased access and pharmacological advances, racial/ethnic disparities in treatment remain. Racial and ethnic minoritized (REM) populations are more likely to enter SUD treatment later, less likely to finish treatment, and have worse treatment outcomes relative to their White counterparts (Baird et al., 2022; Montgomery et al., 2020; Sahker et al., 2020). Further research needs to address disparities in substance use treatment and research. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 7, 2023 Category: Addiction Authors: LaTrice Montgomery, Kathy Burlew, Caravella McCuistian Source Type: research

Health care use and cost of treatment for adolescents and young adults with opioid use disorder
This study calculated the health care utilization and cost of MOUD treatment, other substance use disorder treatment, and general health care for adolescents and young adults receiving treatment for opioid use disorder. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 6, 2023 Category: Addiction Authors: Stephen Orme Source Type: research

A mixed methods exploration of injection drug use risk behaviors and place-based norms in Ukraine
Despite global reductions in HIV incidence and significant investment in local harm reduction services, Ukraine continues to experience high HIV and HCV prevalence among people who inject drugs (PWID). Place-based factors and social norms affect drug use –related risk factors, but research has paid little attention to the relationship between drug use practices and place in Ukraine, including how these factors may contribute to or protect against HIV/HCV risk. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 4, 2023 Category: Addiction Authors: Jill Owczarzak, Jennifer Sanderson Slutsker, Alyona Mazhnaya, Karin Tobin, Tetiana Kiriazova Source Type: research

Lessons learned from employing Medicaid-funded peer recovery support specialists in residential substance use treatment settings: An exploratory analysis
This article explores the experiences of peer recovery support specialists (PRSS) and their colleagues working in residential adult services (RAS) facilities in a rural state to better understand how the role has been implemented in this setting. In West Virginia, PRSS and RAS services have been covered by Medicaid since 2018 for the treatment of substance use disorder (SUD). Thus, the aim of this study is to uncover what has and has not worked well in the early years of service implementation from the perspectives of both PRSS and their colleagues working in the SUD field. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 4, 2023 Category: Addiction Authors: Rebecca Wallis, Miranda Signorelli, Herb Linn, Thomas Bias, Lindsay Allen, Stephen M. Davis Source Type: research

Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
The opioid epidemic continues to be a public health crisis that has worsened during the COVID-19 pandemic. Medications for opioid use disorder (MOUD) are the most effective way to reduce complications from opioid use disorder (OUD), but uptake is limited by both structural and individual factors. To inform strategies addressing individual factors, we evaluated patients' preferences and trade-offs in treatment decisions using conjoint analysis. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 4, 2023 Category: Addiction Authors: Dharushana Muthulingam, Thomas C. Hassett, Lynn M. Madden, Daniel J. Bromberg, Liana Fraenkel, Frederick L. Altice Source Type: research

Medications for opioid use disorder in rural primary care practices: Patient and provider experiences
The opioid epidemic has exacted a significant toll in rural areas, yet adoption of medications for opioid use disorder (MOUD) lags. The Rural Access to Medication Assisted Treatment in Pennsylvania (RAMP) Project facilitated adoption of MOUD in rural primary care clinics. The purpose of this study was to gain a better understanding of the barriers and facilitators operating at multiple levels to access or provide MOUD in rural Pennsylvania. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - August 3, 2023 Category: Addiction Authors: Nora C. Bridges, Rachel Taber, Abigail L. Foulds, Todd M. Bear, Renee M. Cloutier, Brianna L. McDonough, Adam J. Gordon, Gerald T. Cochran, Julie M. Donohue, Dale Adair, Ellen DiDomenico, Janice L. Pringle, Walid F. Gellad, David Kelley, Evan S. Cole Source Type: research